| Product Code: ETC9960892 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Biotechnology Services Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Biotechnology Services Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Biotechnology Services Market - Industry Life Cycle |
3.4 United States (US) Biotechnology Services Market - Porter's Five Forces |
3.5 United States (US) Biotechnology Services Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 United States (US) Biotechnology Services Market Revenues & Volume Share, By Industry, 2021 & 2031F |
3.7 United States (US) Biotechnology Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Biotechnology Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare solutions |
4.2.2 Growing investments in research and development (RD) within the biotechnology sector |
4.2.3 Technological advancements leading to innovative biotechnology services |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for biotechnology products and services |
4.3.2 High costs associated with biotechnology RD and services |
4.3.3 Limited access to skilled professionals and expertise in the biotechnology field |
5 United States (US) Biotechnology Services Market Trends |
6 United States (US) Biotechnology Services Market, By Types |
6.1 United States (US) Biotechnology Services Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Biotechnology Services Market Revenues & Volume, By Service Type, 2021- 2031F |
6.1.3 United States (US) Biotechnology Services Market Revenues & Volume, By Public Engagement Activities, 2021- 2031F |
6.1.4 United States (US) Biotechnology Services Market Revenues & Volume, By Health Education and Research, 2021- 2031F |
6.1.5 United States (US) Biotechnology Services Market Revenues & Volume, By Food Biotechnology Services, 2021- 2031F |
6.1.6 United States (US) Biotechnology Services Market Revenues & Volume, By Donor Recruitment, 2021- 2031F |
6.1.7 United States (US) Biotechnology Services Market Revenues & Volume, By Tissue Collection, 2021- 2031F |
6.1.8 United States (US) Biotechnology Services Market Revenues & Volume, By Cell Processing and Isolation, 2021- 2031F |
6.2 United States (US) Biotechnology Services Market, By Industry |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Biotechnology Services Market Revenues & Volume, By Clinical Research Organizations(CROs), 2021- 2031F |
6.2.3 United States (US) Biotechnology Services Market Revenues & Volume, By Contract Manufacturers Organizations (CMOs), 2021- 2031F |
6.2.4 United States (US) Biotechnology Services Market Revenues & Volume, By Contract Research and Manufacturing Services (CRAMS), 2021- 2031F |
6.3 United States (US) Biotechnology Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Biotechnology Services Market Revenues & Volume, By Pharmaceutical, 2021- 2031F |
6.3.3 United States (US) Biotechnology Services Market Revenues & Volume, By Biotechnological, 2021- 2031F |
6.3.4 United States (US) Biotechnology Services Market Revenues & Volume, By Academic, 2021- 2031F |
6.3.5 United States (US) Biotechnology Services Market Revenues & Volume, By Clinical Trial, 2021- 2031F |
6.3.6 United States (US) Biotechnology Services Market Revenues & Volume, By Healthcare Sectors, 2021- 2031F |
7 United States (US) Biotechnology Services Market Import-Export Trade Statistics |
7.1 United States (US) Biotechnology Services Market Export to Major Countries |
7.2 United States (US) Biotechnology Services Market Imports from Major Countries |
8 United States (US) Biotechnology Services Market Key Performance Indicators |
8.1 Research and development (RD) expenditure in the biotechnology sector |
8.2 Number of patents granted for biotechnology innovations |
8.3 Adoption rate of advanced biotechnology services and solutions |
8.4 Number of partnerships and collaborations within the biotechnology industry |
8.5 Rate of successful commercialization of biotechnology products and services |
9 United States (US) Biotechnology Services Market - Opportunity Assessment |
9.1 United States (US) Biotechnology Services Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 United States (US) Biotechnology Services Market Opportunity Assessment, By Industry, 2021 & 2031F |
9.3 United States (US) Biotechnology Services Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Biotechnology Services Market - Competitive Landscape |
10.1 United States (US) Biotechnology Services Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Biotechnology Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here